Ondine Biomedical Inc (OBI) NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Ondine Biomedical to start phase three Steriwave clinical trial
17 December 2024 12:32
(Sharecast News) - Ondine Biomedical announced on Tuesday that it would begin its phase three 'LANTERN' clinical trial for its novel nasal photodisinfection technology, branded as Steriwave outside...
-
Ondine raising £8.5m to fund US clinical trial
1 November 2024 10:47
(Sharecast News) - Ondine Biomedical announced a proposed minimum £8.5m fundraising through a placing and subscription of new shares on Friday, priced at 8.5p each, to support the US phase three clinical...
-
Ondine Biomedical gets UAE approval for Steriwave
18 October 2024 12:04
(Sharecast News) - Ondine Biomedical announced on Friday that it has received regulatory approval to market its 'Steriwave' nasal decolonisation technology in the United Arab Emirates.
-
Ondine Biomedical's Steriwave added to NHS Supply Chain
21 June 2024 13:14
(Sharecast News) - Life science company Ondine Biomedical announced on Friday that its 'Steriwave' nasal photodisinfection treatment was now available through the NHS Supply Chain.
-
Ondine reports significant financial growth
24 April 2024 15:09
(Sharecast News) - Ondine Biomedical reported significant growth in a trading update on Wednesday, with revenues doubling to $1.2m in 2023, driven by expanded hospital deployments of 'Steriwave'.
-
Ondine Biomedical assessing Steriwave with Yorkshire partners
5 March 2024 13:50
(Sharecast News) - Ondine Biomedical announced on Tuesday that it is joining forces with the Mid Yorkshire Teaching NHS Trust, Health Innovation Yorkshire and Humber, and the York Health Economics Consortium...
-
Ondine raises $3.6m to help commercialise Steriwave
13 December 2023 14:43
(Sharecast News) - Life sciences company Ondine Biomedical has successfully raised CAD 4.91m ($3.62m), it announced on Wednesday, bolstering its efforts to commercialise its photodisinfection technology...
-
Ondine reports strong research findings from Canadian hospitals
23 October 2023 12:15
(Sharecast News) - Ondine Biomedical announced ground-breaking research findings from Vancouver General and University of British Columbia (UBC) Hospitals in British Columbia, Canada, on Monday, after they...
-
Ondine announces expanded Canadian availability of Steriwave
13 October 2023 16:15
(Sharecast News) - Life sciences company Ondine Biomedical announced the expansion of the availability of its Steriwave nasal photo disinfection technology on Friday across various hospitals in Canada.
-
Ondine disinfection tech to be used at another Canadian hospital
7 August 2023 10:57
(Sharecast News) - Ondine Biomedical announced on Monday that it is joining forces with Canada's Kelowna General Hospital (KGH) in a pilot targeting the prevention of hospital-acquired infections (HAIs).
-
Ondine Biomedical reports first-quarter progress
17 April 2023 12:06
(Sharecast News) - Life sciences company Ondine Biomedical reported a number of operational highlights in a first-quarter update on Monday, including clinical developments for US market approval, additional...
-
Ondine Biomedical upbeat on photodisinfection study
17 January 2023 17:30
(Sharecast News) - Ondine Biomedical said on Tuesday that a new study published in the journal Antibiotics found that antimicrobial photodisinfection therapy (aPDT) using its proprietary methylene blue-based...
Company announcements Announcements
-
Ondine commencing US Phase 3 clinical trial
17 December 2024 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Notification of Major Holdings
25 November 2024 17:00
M&G
-
Notification of Major Holdings
22 November 2024 10:31
Ondine Biomedical Inc. NPV (CDI)
-
Director Holdings
22 November 2024 08:30
Ondine Biomedical Inc. NPV (CDI)
-
NOTIFICATION OF MAJOR HOLDINGS
18 November 2024 17:00
Ondine Biomedical Inc. NPV (CDI)
-
Final Result of Fundraise & TVR
15 November 2024 15:30
Ondine Biomedical Inc. NPV (CDI)
-
Updated Result of Fundraise
14 November 2024 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Update on Private Placement and Placing
11 November 2024 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Result of Fundraise
1 November 2024 15:34
Ondine Biomedical Inc. NPV (CDI)
-
Proposed Fundraise
1 November 2024 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Related Party Transaction
30 October 2024 17:30
Ondine Biomedical Inc. NPV (CDI)
-
King’s College Hospital to run Steriwave pilot
23 October 2024 07:00
Ondine Biomedical Inc. NPV (CDI)
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.